63

DAFTAR PUSTAKA

Adibhatla, R. M., Hatcher, J. F., 2005, Cytidine 5-Diphosphocholine
(CDP-choline) in Stroke and other CNS disorder, Journal
Neurochemistry Res., 70: 133-139.

Alawneh, J.,Clathwrthy, P., Morris R., Warburton E., 2008, Clinical
Evidence: Stroke Management, Neuroprotective Agents, British
Medical Journal 140 (2): 1-5.
Alhusni, E. A.Y., 2013, Perbandingan Efektivitas Pirasetam Dan Sitikolin
Pada Pasien Stroke Iskemik Di Bangsal Rawat Inap RSUD Undata
Palu, Tesis, M.Sc.,Fakultas Farmasi, Universitas Gadjah Mada,
Yogyakarta.
Assosiasi Alzheimer Indonesia, 2004, Konsensus Pengenalan Dini dan
Penatalaksanaan Demensia Vaskular, Jakarta, Assosiasi
Alzheimer Indonesia.

Baum, C., Robert T., Nicol K.B., Lisa Z., Sabrina M. F., Mahnaz, H., et
al., 2008, The Montreal Cognitive Assessment (MoCA),Stroke
Engine Assess, Diakses pada 7 Oktober 2012,
<http://strokengine.ca/assess/module_moca_indepth-
en.html#section2>
Bullock, R., 2005, Mild Cognitive Impairment Medical Progres, Oxfords
University Press, pp: 336-338.

Davalos A., J. Castillo, Jose A. S., Julio J. S., Joan M., Sonia L., et al.
2002, Oral Citicoline in Acute IschemicStroke: An Individual
Patient Data Pooling Analysis Of Clinical Trials, Journal of
American Heart Association, 33: 28502857.

Dong, Y. H., Vijay, K. S., Bernard P. L. C., Narayanaswamy V., Hock, L.
T., Raymond, C. S. S.,et al, 2010, The Montreal Cognitive
Assessment (MoCA) is superior to the Mini-Mental State
Examination (MMSE) for the detection of vascular cognitive
impairment after acute stroke, Journal of the Neurological
Sciences, 299 (1): 5-18, diakses 25 September
2012,http://www.jns-
journal.com/article/S0022510X%2810%2900418-1/abstract

Desmond, D. W., Joan, T. M., Mary, S., Yaakov, S., 1996, Recovery of
Cognitive Function After Stroke, Stroke, 27: 1798-1803.

64

Evans, G. J., Flicker, L., 2001, Piracetam for dementia or cognitive
impairment (Review), The Cochrane Database of Systematic
Reviews Issue 2, John Wiley & Sons, London. UK.

Erkinjuntii T., 2007., Vascular Cognitive Deterioration and Stroke.,
Cerebrovascular Disseassa, 24 Suppl 1:189-94.

Fagan, S. C., 2008, Stroke, in Dipiro, J. T., Robert, L. T., Gary, C. Y.,
Gary, R. M., Barbara, G. W., L. Michael, P., Pharmacotherapy,
Pathophysologi Approach,7
th
ed., The Mc-Graw Hill Companies,
USA, pp 376.

Fioravanti, M., Ann E. B., 2006, Citicoline (Cognizin) in the treatment of
cognitive impairment, Clinical Interventions in Aging, 1(3): 247
251.

Firmansyah R., 2007, Gangguan kognitif pada penderita stroke
merupakan prediktor terjadinya demensia, Tesis, Sp.S.,
Universitas Gajah Mada, Yogyakarta.
Ginsberg, Lionel, 2007, Lecture Notes Neurology, EGC, Jakarta. hal.50-58.
Gofir, A, 2011, Manajemen Stroke, Cendikia Press, Yogyakarta. hal.1-
244.
Goldstein, L., B., Adams, R., Alberts, M. J., Apple, L., J., Brass, L., M.,
Bushnell, C., D., et al., 2011, Primary Prevention of Ischemic
Stroke: A Guideline from the American Heart
Association/American Stroke Association Stroke Council,
American Heart Association,37: 1583-1633.

Harms, H.,Halle, E., Maisel, A., 2004, Post Stroke Infection, Diagnosis,
Prediction, Prevention and Treatment to Improves Patients
Outcome, Europe Neurology Review, 63: 40-52.

Heart and Stroke Foundation, 2008, Ischemic Stroke and Hemorrhagic
StrokeHeart and Stroke Journaldiakses 16 Oktober 2012,
<http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3483933/
k.CD67/Stroke.htm>,

Husein, N., Silvia L., Yetty R., Herqutanto, 2010, Uji Validitas dan
Reabilitas Montreal Cognitive Assessment Versi Indonesia
(MoCA-Ina) Untuk Skrinning Gangguan Fungsi Kognitif, Neurona
Neuro Sains, 27(4):15-22.
65

Ikawati, Z., 2011, Farmakoterapi Sistem Saraf Pusat, Bursa Ilmu,
Yogyakarta, hal. 145-167.

Indiana Stroke Task Force. 2006, Recomendations and Guidelines for:
Recognition and Intervention of Risk Factors for Stroke, Diagnosis
and Treatment of Transient Ischemic Attack, Diagnosis and
Treatment of Ischemic Stroke cit Gofir,A.,2011, Manajemen
Stroke,hal.85.

Junaidi, I., Dorce, T., (ed), 2011, Stroke Waspadai Ancamannya, ANDI
OFFSET, Yogyakarta, hal. 13-17.

Keil, U., Scherping, I., Hauptman, S., Schuessel, K., Eckert, A., Muller,
W, E., 2006, Piracetam Improves Mitochondrial Dysfunction
Following Oxidative Stress, British Journal Pharmacol, 147 (2):
199-208.
Kessler, J., Theil, A., Karbe, H., Heiss, W., D., 2000, Piracetam Improves
Activated Blood Flow and Facilitates Rehabilitation of Poststroke
Aphasic Patient, American Heart Association, 31: 2112.

Koda Kimble, M. A.,Young, L. Y., Alldredge, B. K., Corelli, R. L.,
Guglielmo, B. J., Kradjan, W. A., et al., 2009, Applied
Therapeutics: The Clinical Use of Drugs, 9th Edition, Lippincott
Williams & Wilkins, Philadelphia.

Kowalak, J. P., William, W.,Brenna, M., 2003, Professional Guide To
Pathophysiology, Diterjemahkan dari Bahasa Inggris oleh Renata
Komalasari, Anastasia O. T. dan Monica Ester, EGC, Jakarta.
Leys, D., Henon, H., Mackowiak, C. MA., Pasquier, 2005, Poststroke
Dementia, Lancet Neurology4 (11): 752-759.
Lumbantobing, S.M., 2012, Neurologi Klinik Pemeriksaan Fisik dan
Mental, FK UI, Jakarta, hal: 152-193.
Misbach, J., S. M. Lumbantobing, Rusdi L., Teguh A. S., Adelina, Y.,
Fauziah B., et al., 2007, PERDOSSI Guideline Stroke, Kelompok
Studi Stroke Perhimpunan Dokter Spesialis Saraf Indonesia,
Jakarta. hal: 85-91.
Misbach, J., Rusdi L., Amiruddin, A.,Basyiruddin, A., Suroto, Adelina, Y.,
et al., 2011, PERDOSSI Guideline Stroke, Kelompok Studi Stroke
Perhimpunan Dokter Spesialis Saraf Indonesia, Jakarta, hal: 81.
Mahapatra, A. K., Agrawal, D., Kumar, R., 2008, Review Article: Minor
Head Injury,Indian Journal of Neurotrauma (IJNT), 5(2): 59-62
66

Nasreddin, Z., N. Phillips, H. Chertkow, 2005, Test and Instructions
Montreal Cognitive Assessmet (MoCA),viewed 25 September
2012,<http://www.mocatest.org/default.asp>

Nehlig, A., 2010, Is Caffeine a Cognitive Enhancer?, Journal of
Alzheimers Disease, 20: S85-S94.

Nunes, B., Silva RD., Cruz VT., 2010, Prevalence and Pattern of
Cognitive Impairment in Rural Urban Population From Northern
Portugal., BMC Neurology, 10-42.

Purba, J. S., 2008, Efek Terapi SitikolinTerhadap Perbaikan Struktur dan
Fungsi Membran Sel Otak pada Penderita Stroke, Medicinus
(Scientifc Journal of PharmaceuticalDevelopment and Medical
Application), 22: 55-57.

Qureshi Al., 2005, Ciggarette Smoking Among spouses: Another risk
factor for stroke in Women, Stroke; 36:e74-e76 cit.Gofir,A.,2011,
Manajemen Stroke,hal.85.

Qureshi, I., Endres, R.J., 2010, Citicoline: A Novel Therapeutic Agent
With Neuroprotective, Neuromodulatory and Neurogenerative
Propertise, Natural Medicene Journal, 2 (6): 1-11.

Rasquin, S., Verhey, F., Van O. R., Lousberg, R., Lodder, J., 2004,
Demographic and CT scan Features Related to Cognitive
Impairment in The First Year After Stroke, Journal Nuerology
Neurosurgery Psychiatry, 75: 1562-1567.
Reeves, M. J., Gregg C., Fonarow, Xin Z., Eric, E. S., Lee, H. S., 2009,
Quality of Care in Women With Ischemic Stroke in the GWTG
Program, Stroke: A Guideline from the American Heart
Association/American Stroke Association Stroke Council,
American Heart Association40: 1127-1133.
Rosjidi, C., H., Nurhidayat, S., 2008, Buku Ajar Perawatan Cedera
Kepala dan Stroke, Ardana Meia: Yogyakarta, Hal: 143-188.
Sacco, RL., Shi T., Zamanillo MC., Kargman DE., 2006., Predictors of
mortality and recurrence after hospitalizedcerebral infarction in an
urban community: The Northern Manhattan Stroke Study
Neurology, 44:626-634.

Sabin, J. A., Gustavo C. R., 2011., Citicoline in Vascular Cognitive
Impairment and Vascular Dementia After Stroke., American Heart
Association., Stroke; 42.

67

Smith, T., Nadia G., Clive, H., 2007, The Montreal Cognitive Assessment:
Validity and Utility in a Memory Clinic Setting, The Canadian
Journal of Psychiatry, 52(5): 329-332.

Susilo H., 2009, Brain Protection pada Stroke Akut, PERDOSSI, The 7
th

National Biennial Meeting PERDOSSI, Medan 24- 26 Juni,
Majalah Farmacia9 (2): 50.

Setyopranoto, I., Lamsudin, R., 2006. Peranan Stroke Iskemik Akut
Terhadap Timbulnya Gangguan Fungsi Kognitif di RSUP. dr.
Sardjito Yogyakarta, Jurnal Fakultas Kedokteran UGM, 7(3): 127-
137.

Sweetman, S. C., 2009, Madrtindale The Complete Drug Reference
36
th
edition, Pharmaceutical Press, London, UK.

Syifa N., 2010, Kajian Efektivitas Penggunaan Pirasetam dan Sitikolin
pada Pasien Stroke dengan Menggunakan NIHSS di Bangsal Rawat
Inap RS PKU Muhammadiyah Yogyakarta, Tesis, MSc., Fakultas
Farmasi, Universitas Gajah Mada, Yogyakarta.

Tampubolon, A., 2008. Hubungan Lokasi Infark dengan Timbulnya
Demensia Pasca Stroke, Tesis, Sp.S, Fakultas Kedokteran,
Universitas Diponegoro, Semarang.

Ustrell, R.X., 2007, Stroke, Diagnosis and Therapeutic Management of
Cerebrovascular Desseasse; 34: 338-400.
Wheble, P. C. R., Emily S. S., Malcolm R. M., 2007, A Systematic
Review and Meta-Analysis ofthe Efficacy of Piracetam and
Piracetam-LikeCompounds in Experimental Stroke, Cerebrovasc
Dis, 25:511.

Yayasan Stroke Indonesia, 2011, Sekilas Tentang Stroke, Jakarta; Yayasan
Stroke Indonesia.